Article Information
PubMed
Print ISSN
Online ISSN
History
- Received August 26, 2013
- Accepted January 6, 2014
- Published online February 12, 2014.
Article Versions
- Earlier version (January 6, 2014 - 11:49).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Patrik Lundquist,
- Gunilla Englund,
- Cristine Skogastierna,
- Johan Lööf,
- Jenny Johansson,
- Janet Hoogstraate,
- Lovisa Afzelius, and
- Tommy B. Andersson
- CNS and Pain Innovative Medicines DMPK, AstraZeneca R&D, Södertälje, (P.L., G.E., C.S., J.L., J.J., J.H., L.A.); Cardiovascular and Gastrointestinal Innovative Medicines DMPK, AstraZeneca R&D, Mölndal, (P.L., T.B.A.); Department of Pharmacy, Uppsala University, Uppsala, (P.L.); and Section of Pharmacogenetics, Departments of Physiology and Pharmacology, Karolinska Institutet, Stockholm, (T.B.A.), Sweden
- Address correspondence to:
Dr. Tommy B. Andersson, Cardiovascular and Metabolic Diseases Innovative Medicines DMPK, AstraZeneca R&D, Pepparedsleden 1, SE-431 83 Mölndal, Sweden. E-mail: Tommy.B.Andersson{at}astrazeneca.com